Clerkenwell Health, a psychedelic-specialist clinical research organisation, has raised £2.1m in seed funding, bringing the total to date up to £2.5m, which will be used to get the London startup-based fully operational. Investors include Lionheart Ventures, Convergence Partners, and Exceptional Ventures, which was co-founded by Paolo Pio (former MD Europe at Joyance Partners) and Matt […]
Clerkenwell Health raises £2.1m to test the new wave of psychedelics treatments by Mike Butcher originally published on...